aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Gene Therapies
Technology
Biotech
Tags
Healthtech
Model Types
Platform
Customer Type(s)
Consumers
Geographic Exposure
Global
When was Carmine Therapeutics founded?
Carmine Therapeutics was founded in 2019.
Where is Carmine Therapeutics’s headquarters located?
Carmine Therapeutics’s headquarters is located in Cambridge, MA, US.
How many employees does Carmine Therapeutics have?
Carmine Therapeutics has 39 employees as of Feb 5, 2024.
How much has Carmine Therapeutics raised to-date?
As of July 05, 2023, Carmine Therapeutics has raised a total of $3.4M (USD) since Oct 13, 2022.
Add Comparison
Total Raised to Date
$3.4M
USD
Last Update Oct 13, 2022
Total Employees Over Time
39
As of Feb 2024
Carmine Therapeutics Address
700 Main Street
Cambridge,
Massachusetts
MA 02139
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts